Daniell Henry, Ruiz Gricel, Denes Bela, Sandberg Laurence, Langridge William
Department of Molecular Biology and Microbiology, University of Central Florida, College of Medicine, Orlando, FL 32816-2364, USA.
BMC Biotechnol. 2009 Apr 3;9:33. doi: 10.1186/1472-6750-9-33.
Transgenic chloroplasts are potential bioreactors for recombinant protein production, especially for achievement of high levels of protein expression and proper folding. Production of therapeutic proteins in leaves provides transgene containment by elimination of reproductive structures. Therefore, in this study, human Insulin like Growth Factor-1 is expressed in transgenic chloroplasts for evaluation of structural identity and function.
Expression of the synthetic Insulin like Growth Factor 1 gene (IGF-1s, 60% AT) was observed in transformed E. coli. However, no native IGF-1 gene (IGF-1n, 41% AT) product was detected in the western blots in E. coli. Site-specific integration of the transgenes into the tobacco chloroplast genome was confirmed after transformation using PCR. Southern blot analysis confirmed that the transgenic lines were homoplasmic. The transgenic plant lines had IGF-1s expression levels of 11.3% of total soluble protein (TSP). The IGF-1n plants contained 9.5% TSP as IGF-1n, suggesting that the chloroplast translation machinery is more flexible than E. coli in codon preference and usage. The expression of IGF-1 was increased up to 32% TSP under continuous illumination by the chloroplast light regulatory elements. IgG-Sepharose affinity column chromatographic separation of Z domain containing chloroplast derived IGF-1 protein, single and two dimensional electrophoresis methods and mass spectrometer analysis confirmed the identity of human IGF-1 in transgenic chloroplasts. Two spots analyzed from 2-D focusing/phoresis acrylamide gel showed the correct amino acid sequence of human IGF-1 and the S. aureus Z-tag. Cell proliferation assays in human HU-3 cells demonstrated the biological activity of chloroplast derived IGF-1 even in the presence of the S. aureus Z tag.
This study demonstrates that the human Insulin like Growth Factor-1 expressed in transgenic chloroplasts is identical to the native protein and is fully functional. The ability to use plant chloroplasts as bioreactors to generate proteins of great economic value that retain their biological activity is an exciting and achievable goal that appears to be within our grasp.
转基因叶绿体是重组蛋白生产的潜在生物反应器,尤其有助于实现高水平的蛋白表达和正确折叠。在叶片中生产治疗性蛋白可通过消除生殖结构实现转基因的隔离。因此,在本研究中,人胰岛素样生长因子-1在转基因叶绿体中表达,以评估其结构一致性和功能。
在转化的大肠杆菌中观察到合成的胰岛素样生长因子1基因(IGF-1s,AT含量60%)的表达。然而,在大肠杆菌的蛋白质免疫印迹中未检测到天然IGF-1基因(IGF-1n,AT含量41%)的产物。通过PCR确认转基因在转化后定点整合到烟草叶绿体基因组中。Southern印迹分析证实转基因株系是同质的。转基因植株系中IGF-1s的表达水平占总可溶性蛋白(TSP)的11.3%。IGF-1n植株中IGF-1n占TSP的9.5%,这表明叶绿体翻译机制在密码子偏好和使用方面比大肠杆菌更具灵活性。在叶绿体光调节元件的持续光照下,IGF-1的表达增加至占TSP的32%。通过IgG-琼脂糖亲和柱色谱分离含Z结构域的叶绿体衍生IGF-1蛋白、一维和二维电泳方法以及质谱分析确认了转基因叶绿体中人IGF-1的身份。从二维聚焦/电泳丙烯酰胺凝胶分析的两个斑点显示了人IGF-1和金黄色葡萄球菌Z标签的正确氨基酸序列。在人HU-3细胞中的细胞增殖试验证明了叶绿体衍生的IGF-1即使在存在金黄色葡萄球菌Z标签的情况下也具有生物活性。
本研究表明在转基因叶绿体中表达的人胰岛素样生长因子-1与天然蛋白相同且具有完全功能。利用植物叶绿体作为生物反应器来生产具有经济价值且保留其生物活性的蛋白质的能力是一个令人兴奋且可实现的目标,似乎已在我们的掌握之中。